Fixed-dose combination of antiretrovirals for the treatment of adult and adolescent patients aged ≥12 years (≥35 kg) with HIV-1. Used as part of a combination treatment regimen. Its composition results in lower long-term bone and renal impact.
Drivelea
It is a fixed dose combination drug indicated for VIH positive patients and HLA-B*5701 negative patients, without hepatitis B virus.
Benjor
Antiretroviral, integrase inhibitor, indicated as part of the treatment for patients with HIV infection.
Tenofovir
Antiretroviral to treat HIV-caused infection, associated with other antivirals.
Simplir
Fixed combination of antiretroviral, indicated to treat HIV-caused infection.
Remivir
Fixed combination of antiretrovirals, nucleoside inhibitors of viral transcriptase Indicated to treat HIV-caused infection or for pre-exposure prophylaxis.
Nevirapina Elea
Antiretroviral to treat HIV-caused infection.
Lisotyr
Fixed combination of analogous antiretroviral, nucleoside reverse transcriptase inhibitor, indicated to treat HIV-caused infection.
Damaris
Fixed combination of analogous antiretrovirals, nucleoside reverse transcriptase, indicated to treat HIV-caused infection.
3-Tc/Azt Elea
Fixed combination of analogous antiretrovirals, nucleoside reverse transcriptase, indicated to treat HIV-caused infection.
